Phraxis, Inc. has successfully completed the world’s first commercial case using its FDA-approved EndoForceAnastomotic Connector, establishing a pivotal milestone in dialysis vascular access innovation. The groundbreaking procedure, performed at Spartanburg Regional Medical Center in South Carolina, signals the beginning of U.S. commercialisation for this novel endovascular device designed to standardise arteriovenous graft creation.
Abbott has received CE mark approval in Europe for an expanded indication of its Navitor™ transcatheter aortic valve implantation (TAVI) system, significantly broadening treatment options for patients with symptomatic, severe aortic stenosis. The minimally invasive device is now approved for patients at low or intermediate surgical risk, complementing its existing approval for high and extreme-risk […]
Comprehensive cardiac monitoring reveals that low aerobic fitness and advancing age independently drive irregular heartbeat patterns previously dismissed as benign, with implications for preventive screening strategies starting at age 50.
Researchers from the International Brain Laboratory have unveiled the first brain-wide activity map showing how decision-making unfolds across the entire brain in mice at single-cell resolution. The comprehensive study recorded from over 621,000 neurons across 279 brain areas, revealing that decision-making is distributed across many regions in a highly coordinated way.
A major international clinical trial has overturned four decades of standard cardiac care, finding that beta-blockers provide no benefit for most heart attack survivors with preserved heart function. The REBOOT study, involving over 8,500 patients, could reshape treatment guidelines worldwide.
The Society of Nuclear Medicine and Molecular Imaging has unveiled a comprehensive digital platform designed to streamline patient access to radiopharmaceutical clinical trials. The Global Radiopharmaceutical Trial Finder utilises artificial intelligence to match patients, physicians, and researchers with relevant studies across multiple international registries, addressing critical gaps in clinical trial participation rates.
A groundbreaking diagnostic test measuring brain blood flow dynamics has demonstrated superior accuracy in detecting Alzheimer’s disease compared to traditional markers, achieving a 96% diagnostic performance rate. The non-invasive cerebrovascular test offers hope for earlier, more accessible dementia screening whilst challenging conventional amyloid-focused diagnostic approaches.
Researchers at the University of Minnesota Twin Cities have demonstrated a groundbreaking process that combines 3D printing, stem cell biology, and lab-grown tissues for spinal cord injury recovery. The innovative approach uses microscopic channels to guide neural regeneration, offering new hope for treating complete spinal cord injuries.
Researchers have developed PathoPlex, a new multiplexed imaging technology capable of mapping over 140 proteins within cells at subcellular resolution. The framework identified kidney stress-related protein patterns in people with type 2 diabetes before clinical signs of disease appeared, potentially accelerating both diagnosis and treatment timelines.
Hologic has secured the prestigious MedTech Breakthrough Award for “Best New Imaging Technology Solution,” with its Genius AI Detection PRO mammography platform earning recognition amongst record-breaking international competition from leading medical technology innovators across more than 18 countries.
Prins Hendrikstraat 1
5611HH Eindhoven
The Netherlands
info@interhospi.com
PanGlobal Media IS not responsible for any error or omission that might occur in the electronic display of product or company data.
